Our mission is to improve lives through genomics, all around the globe. As a result, WuXi NextCODE is focused on bringing high quality sequencing and analysis to everyone who needs it.
Sequencing has become steadily less expensive and more available, but there are still parts of the world where people who desperately need it cannot access it. Finding the important variants within this sequence data depends not just on accurate and high quality sequencing, but also on powerful analytics and access to population scale genomic data to be able to uncover pathogenic variants versus those that are benign, or even “possibly” pathogenic.
One way we stand apart is that our products and services span study design, sample preparation, sequencing, secondary and tertiary analysis, storage (including cloud-based), interpretation, scalable analytics, as well as AI and deep learning. All these activities are backed by the most proven and widely-used technology for organizing, mining, and sharing genome sequence data – the proprietary GOR data analysis platform and associated analytical tools.
We are a fully integrated contract genomics organization (CGO) and have built what is emerging as the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics, drug discovery and development, and wellness initiatives and enterprises using the genome to improve health around the world.